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Abstract We investigated the 5P-flanking promoter region of
the rat somatostatin receptor subtype 3 (rSSTR3). Using a
cDNA probe, genomic clones containing the 5P-flanking promo-
ter region of the rSSTR3 gene were isolated. A sequence of 5.4
kb directly upstream from the start codon was analyzed and two
introns were found in the 5P untranslated region (UTR) of the
cDNA sequence. The transcriptional initiation site was deter-
mined by 5P rapid amplification of cDNA ends (RACE), primer
extension and RNase protection analysis with cerebellar RNA.
Two major transcriptional initiation sites were found at position
31040 (tsp1) and 3856 (tsp2) relative to the translational
initiation site. Like a number of other promoters of G-protein-
coupled receptors, the rSSTR3 gene lacks TATA and CAAT
motifs and includes G+C-rich regions. Functional analysis of the
promoter region by transfecting rSSTR3 luciferase-reporter gene
constructs into rat pituitary GH3 cells and HEK 293 cells
indicated that a 107-bp region upstream of tsp2 was sufficient to
drive transcription. Furthermore a 562-bp region at position
31304 to 31865 upstream of the ATG start codon exerted a
negative regulatory effect on transcriptional activity.
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1. Introduction
Many neurotransmitter receptors occur in numerous di¡er-
ent subtypes or isoforms, which frequently exhibit only mar-
ginal di¡erences in terms of receptor function. This is partic-
ularly true for the ¢ve somatostatin receptors (SSTR1^5),
which show very similar patterns in coupling to e¡ector mol-
ecules like adenylyl cyclase or G-protein gated inwardly rec-
tifying potassium channels [1,2]. One of the main di¡erences
between receptor subtypes appears to be the spatial and tem-
poral pattern of expression, which may enable di¡erent cell
types to express SSTRs at the appropriate time during devel-
opment.
SSTR subtypes 1^5 are expressed in the mammalian central
nervous system, and it has been shown that the spatial and
temporal expression pattern of SSTRs in the CNS is highly
subtype speci¢c [3]. Thus, in the cerebellum SSTR1 is mostly
observed in fetal and neonatal rats, whereas SSTR3 is the
major subtype detected in the cerebellum of adult animals
[4]. SSTRs are also highly expressed in various tumors derived
from neuroendocrine tissues; hormone secretion from these
tumors can be inhibited by treatment with several stable pep-
tide analogues of SST, and this constitutes a major clinical use
of somatostatin and its analogues. The regulation of SSTR
expression is therefore of clinical importance, as the e¡ect of
SST analogue treatment on the expression levels of individual
SSTR subtypes in these tumors may determine the e⁄ciency
of the long-term SST treatment.
Limited information is available on the regulation of SSTR
expression; the expression of SSTR1 in the pituitary GH3 cell
line has been shown to be regulated by the transcription fac-
tor Pit1 (Baumeister, Wegner, Richter and Meyerhof, manu-
script submitted). The mouse SSTR2 gene is subject to alter-
native splicing in its 5P-untranslated region, giving rise to three
di¡erent mRNA species that are regulated by three di¡erent
promoters [5]. A common feature among the SSTR subtypes
that have been analyzed so far (rSSTR1, mSSTR4, hSSTR5)
is the lack of TATA and CAAT sequences and the presence of
G+G-rich regions in the 5P-£anking promoter region [6^8].
Here we report a structural and functional analysis of the
5P-£anking region of the gene for the rat SSTR3. The highest
mRNA levels for this receptor have been detected in the hip-
pocampus and the cerebellum of adult animals, whereas the
mRNA is absent from fetal tissues [4,9]. Con£icting results
have been obtained with respect to the presence of SSTR3
in the pituitary, one of the main targets of somatostatin re-
leased from the hypothalamus. We have shown previously
that SSTR3 mRNA is present in the GH3 pituitary tumor
cell line, though the main SSTR subtype expressed in these
cells is SSTR1 [6]. In order to characterize the SSTR3 gene,
we have determined its transcriptional start site using mRNA
isolated from rat cerebellum and from the GH3 cell line. A
functional analysis of the putative promoter region was per-
formed by transfection of luciferase reporter constructs in
GH3 cells.
2. Materials and methods
2.1. Isolation of genomic clones
A rat genomic library in lambda DASH II (Stratagene) was
screened by standard protocols [10] using a [K-32P]-labelled fragment
consisting of the ¢rst 450 bases of the published rSSTR3 cDNA se-
quence [4]. One positive clone, V-19, was analyzed by restriction map-
ping and Southern blot hybridization. EcoRI fragments were sub-
cloned into pBluescript II SK (Stratagene) and sequenced.
2.2. RNA preparation
Total RNA was isolated from adult rat cerebelli and GH3 cells
using the guanidine isothiocyanate/cesium chloride extraction method
[10]. Poly(A) RNA was selected using oligo(dT)-latex particles (Oli-
gotex mRNA Kit, Qiagen, Hilden, Germany) according to the man-
ufacturer’s instructions.
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2.3. Rapid ampli¢cation of cDNA ends (5P-RACE)
cDNA was transcribed using murine Moloney leukemia virus-re-
verse transcriptase (USB, Cleveland, OH, USA) and the speci¢c oli-
gonucleotide 5P-TCTTCAGATGGCACCCA-3P which is complemen-
tary to nucleotides 3472 to 3456 relative to the translational
initiation site of the SSTR3 mRNA. Twenty Wg of total rat cerebellar
RNA was used in the synthesis reaction. Further tailing carried out
using terminal deoxynucleotide transferase (Pharmacia, Freiburg,
Germany) as described [11], followed by a ¢rst ampli¢cation step in
the presence of Taq polymerase, the non-speci¢c oligonucleotide Ri-
Ro(dT) and the speci¢c oligonucleotide 5P-CAGAAGCTTCTTC-
CAAAGATGACAGAAATG-3P (Ra1), complementary to nucleo-
tides 3484 to 3513 of the SSTR3 cDNA. In the second
ampli¢cation step, the two speci¢c oligonucleotides 5P-AGAGGATC-
CGAAAAAGGCAGGGACAGAGGG-3P (Rax), complementary to
3718 to 3747 and 5P-TGGGGATCCTGACAGAGAAGGATTGA-
GCCA-5P (Ra4), complementary to 3777 to 3806 were used as spe-
ci¢c primers together with the non-speci¢c primer Ri [11]. Products
were analyzed by Southern blotting with 32P-end-labelled speci¢c oli-
gonucleotides after electrophoresis in 1% agarose gels and subcloned
into pBluescript II Sk for sequence analysis.
2.4. Primer extension
Primer extension was performed essentially as described [10] using
up to 10 Wg poly(A) RNA isolated from either rat cerebelli or GH3
cells. Yeast tRNA was used as a negative control. 32P-end-labelled
antisense oligonucleotides complementary to nucleotides 3718 to
3747 (Rax), 3777 to 3806 (Ra4), 3884 to 3903 5P-GACAGCAG-
GTGCCAGACTGA-3P (PE2), 3915 to 3944 5P-TTAGGATCCGA-
GGCCAGACCGGGAGAGGGA-3P (Ra5), relative to the transla-
tional initiation site of the coding strand were used. Primers and
RNA were hybridized at 42‡C overnight and extended with MMLV
reverse transcriptase (USB). The reaction products were analyzed on a
6% polyacrylamide/50% urea gel.
2.5. RNase protection
RNase protection assays were performed as described [12]. Several
genomic regions (31294 to 31044, 31125 to 3777, 31125 to 3625)
were ampli¢ed by PCR and subcloned in pBluescript II Sk. Labelled
antisense RNA was generated using T7 RNA polymerase and
[K-32P]CTP following linearization of the construct with EcoRI, yield-
ing transcripts that contained complementary sequences to the corre-
sponding regions of the genomic DNA. The RNase protection assays
were performed using 25 Wg total RNA from cerebellum or 25 Wg
yeast tRNA. RNAs were hybridized overnight at 45‡C. For RNase
digest, various concentrations of RNase A and RNase T1 were used.
The resulting protected fragments were analyzed on a 6% polyacryl-
amide gel containing 50% urea. A dideoxy DNA sequencing reaction
was run as a size marker, and the di¡erence in migration properties
between DNA and RNA was accounted for by calculation using
a factor derived from the migration behavior of the unprotected
band.
2.6. Cell culture and transfection
Rat pituitary GH3 tumor cells were cultured in Ham’s F10 medium
containing 15% horse serum, 2.5% fetal calf serum, 1 mM L-gluta-
mine. Human embryonic kidney (HEK) 293 cells were cultured in
DMEM containing 10% fetal calf serum, 2 mM L-glutamine and 0.1
mg/ml penicillin/streptomycin. rSSTR3 luciferase reporter plasmids
were generated by inserting the appropriate fragments of the genomic
into the multiple cloning site of pGL3Basic (Promega, Madison, WI,
USA).
400 Wl of cell suspension at a density of 5U106^1U107 cells/ml were
transfected with 10 Wg pGL3-Basic or equivalent amounts of rSSTR3
promoter/pGL3-Basic constructs by electroporation (BTX Electropo-
ration System, BTX, San Diego, CA, USA). To determine the trans-
fection e⁄ciency, each plate was cotransfected with 5 Wg of CMVlacZ
vector. The chosen parameters for electroporation were cuvettes with
4-mm gap, 260 V, 800 mF, 720 W.
Cells were harvested 24 h after transfection by scraping and sub-
sequent centrifugation. The cell pellet was washed once with phos-
phate bu¡ered saline and resuspended in 300 Wl lysis bu¡er (100 mM
Tris-acetate, pH 7.8; 10 mM Mg-acetate; 1 mM EDTA; 1% Triton
X-100). After sonication, the cell debris was separated from cytoplas-
mic proteins by centrifugation at 14 000 rpm for 10 min. For lucifer-
ase assays, 10 Wl cell extract was mixed with 50 Wl luciferase assay
reagent (Promega). Measurements were performed in a luminometer
(MicroLumat LB 96 P/EGpG Berthold). For L-galactosidase assays,
20 Wl cell extract was used with o-nitrophenyl-L-D-galactopyranoside
(Sigma; 0.8 mg/ml ¢nal concentration in 0.1 M sodium phosphate,
pH 7.5) as substrate. Enzyme activity was detected by measuring light
absorbance at 420 nm.
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Fig. 1. Structural organization of the rSSTR3 gene. A: Scheme of the rSSTR3 gene showing the location of the two introns (Int-1, Int-2) and
the two transcriptional start sites TSP-1 and TSP-2. B: Organization of the 5P region of the rSSTR3 gene upstream of the translational start
codon. The position of consensus sites for several transcription factors is indicated by thick bars. In the case of the neuronal restrictive silenc-
ing element (NRSE), deviations detected in the SSTR3 gene are underlined. C: Partial sequence upstream of the two transcriptional start sites
showing the location of consensus sequences for the transcription factors AP1, Y1, AP2, CP2, Sp1 and GCF.
M. Glos et al./FEBS Letters 440 (1998) 33^3734
3. Results
3.1. Structure of the rSSTR3 gene
By screening a rate genomic library with a fragment corre-
sponding to the 5P-end of the known cDNA for rSSTR3,
4 positive clones were identi¢ed. Two EcoRI fragments
(3.4 kb and 6.1 kb) of one of these clones contained the 5P-
£anking sequence and the coding region of the rSSTR3 gene.
The structure of the 5P-£anking sequence of the gene is shown
in Fig. 1. By comparison of the published cDNA [4] and the
genomic sequence reported here, two introns were identi¢ed in
the 5P-UTR. The size of the ¢rst intron is 187 bp, the size of
the second intron is about 3.1 kb, 2.1 kb of which were se-
quenced.
Similar to the promoter regions of the other SSTRs [6^8],
the sequence upstream of the translational start site of the
SSTR3 gene contains neither a canonical TATA box nor a
CAAT box.
3.2. Determination of the transcriptional start site
The known cDNA sequence of SSTR3 has a length of 3.9
kb, whereas the SSTR3 mRNA is detected at about 4.4 kb in
Northern blot analysis [4]. As the di¡erence of 500 bp cannot
be accounted for by the poly(A) tail alone, we attempted to
determine the transcriptional start site of the SSTR3 gene.
First we employed the 5P-RACE technique to approach the
5P-end of the mRNA derived from adult rat cerebellum. Upon
sequence analysis several RACE products were identi¢ed (see
Fig. 2) which were colinear with the genomic sequence, adding
roughly 300 bp to the known mRNA sequence. Based on this
sequence information, several primers were built to be used in
primer extension analysis. Primer PE2 yielded a major speci¢c
band corresponding to a transcriptional start site at position
31040 (Fig. 2A; the numbering used from now on is relative
to the ATG start codon and does not count the two introns).
This start site was also found when the primer Ra5 was used.
A second putative transcriptional start site was detected with
primers Rax and Ra4 at a distance of 856 bases from the start
codon. Both start sites were also detected when the primer
extension experiment was performed on poly(A) RNA iso-
lated from GH3 cells (not shown).
To investigate if further introns were present in this region
of the genomic clone, we performed RNAse protection anal-
ysis with cerebellar total RNA using 32P-labelled RNA probes
transcribed in vitro from fragments of the genomic clones
cloned into pBluescript. A probe encompassing the range
from position 31125 to 3777 yielded a speci¢cally protected
band of approx. 260 bp (Fig. 2C). This is in agreement with a
transcriptional start site at position 31040. A second probe,
ranging from position 31125 to 3625 on the genomic se-
quence, protected a fragment of 420 bp (Fig. 2D). This result
again ¢ts to a start site at position 31040. No speci¢cally
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Fig. 2. Analysis of the transcriptional start site of the SSTR3 gene. A: Summary of the results obtained by 5P-RACE, primer extension and
RNase protection. 5P-RACE and primer extension products are indicated by arrows; in the lower panel the probes used for RNase protection
experiments are indicated; the non-protected parts are indicated by dotted lines, the protected parts by solid lines. The oligonucleotides used
for primer extension, 5P-RACE and the generation of probes for RNase protection are shown on top. The two major transcriptional start sites
at 3856 and 31040 are indicated by vertical lines. B: Primer extension using the primer PE2 performed on poly(A) RNA isolated from rat
cerebellum (Cb) and yeast tRNA (Y). The size of the transcript was determined by a sequencing reaction performed on a plasmid containing
the genomic clone using the same primer PE2. The major transcript of 153 bp is indicated by an arrow. C: RNase protection was performed
using cerebellar total RNA (Cb) or yeast tRNA (Y); as probe a fragment of the genomic clone corresponding to position 31125 to 3777 was
used. The concentration of RNase A was 40 mg/ml, the concentration of RNaseT1 was 300 units/ml. In lane P the undigested probe was
loaded. The arrowhead indicates the position of the speci¢cally protected band, the arrow marks the undigested probe. D: A fragment corre-
sponding to position 31125 to 3625 was used. The concentration of RNase T1 was 200 units/ml. Experimental conditions and ¢gure legends
are otherwise identical to C.
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protected bands were observed with a fragment containing
sequence from position 31294 to 31044 upstream to the ¢rst
starting point at position 31040, con¢rming that sequence
upstream to this point is not included in the messenger
RNA (data not shown). Adding the 385 bp of the 5P sequence
identi¢ed here to the 3881 bp of the published rat SSTR3
mRNA sequence and considering a poly(A) tail of about
200 residues, the resulting total length of the mRNA closely
matches the length of 4400 bp that has been observed in
Northern blot analysis [4].
3.3. Functional analysis of the rat SSTR3 promoter
A functional analysis of the SSTR3 promoter region was
performed by transient transfection of luciferase reporter gene
constructs into GH3 cells. This pituitary tumor cell line does
express endogenous SSTR3, albeit at a low level. The domi-
nant somatostatin receptor subtypes in this cell line are
SSTR1 and SSTR2 [6,13]. Nevertheless we could detect the
SSTR3 transcriptional start sites using poly(A) RNA iso-
lated from GH3 cells (see above).
Transfection of the luciferase gene under the control of a
1.2-kb fragment which included the putative promoter region
upstream of the transcriptional start sites into GH3 cells led to
a 5-fold increase in luciferase activity in cell extracts, when
compared to cells transfected with the luciferase vector with-
out an insert. This increase was speci¢c to GH3 cells as it was
not observed upon transfection into HEK 293 cells (Fig. 3A)
which do not express endogenous SSTR3. Further truncation
of this construct from the 5P-end had no e¡ect on promoter
activity until a position at 31292 was reached. With this
construct a further increase in luciferase activity was observed,
which was again not paralleled in HEK293 cells. The highest
promoter activity was observed with a fragment ranging from
position 31152 to 3800. A signi¢cant reduction in activity
was then observed when the 5P-£anking region was shortened
from position 3963 to 3914. Thus a 107-bp fragment (3963
to 3856) immediately upstream of the second transcriptional
start site at position 3856 is su⁄cient to drive transcription of
the rSSTR3 gene in GH3 cells.
A second set of experiments was performed with constructs
in which the 5P-UTR was not truncated at position 3800 but
at position 3200. In these experiments rSSTR3 promoter ac-
tivity was also GH3-cell speci¢c, but it became apparent that
additional regulatory elements might be present in the 5P-
UTR of the gene between 3856 and 3200, as the promoter
activity did not decrease to control levels when these con-
structs were truncated beyond the second transcriptional start
site at position 3856 (data not shown).
From our data it appears that the SSTR3 promoter activity
is restricted by elements in the 5P part of the investigated
sequence. To analyze this further, several constructs were gen-
erated which contained only parts of this region linked to a
promoterless luciferase gene. In cell extracts of GH3 cells
transfected with these constructs a reduced luciferase activity
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Fig. 3. Functional analysis of the SSTR3 promoter. A: Stepwise truncation from the 5P-end of the promoter sequence. Promoter constructs in
the luciferase reporter gene vector pGL3-basic were transfected into GH3 (¢lled bars) or HEK cells (open bars) together with a CMV-lacZ con-
struct. Luciferase activity was normalized to the L-galactosidase activity and is shown as the relative increase when compared to results ob-
tained with the control vector pGL3-basic. The numbers indicate the 5P-ends of the constructs; the 3P-end is at position 3800 in all cases. The
two vertical lines indicate the positions of the two transcriptional start sites at positions 31040 and 3856. B: Identi¢cation of a repressing ac-
tivity in the 5P-end of the promoter. Experimental conditions were identical to A. The numbers indicate the 5P- and 3P-ends of the constructs
used. Experiments using the constructs 32279/31309 and 32279/31865 were performed on GH3 cells only.
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was observed when compared to control cells transfected with
the empty vector, consistent with a negative regulatory e¡ect
of the 5P region of the promoter (Fig. 3B). The strongest
inhibitory e¡ect, a reduction to 10% of the basal level deter-
mined in control cells, was observed with the region from
31865 to 31309; this part of the sequence was also e¡ective
in HEK cells, leading to a reduction of the promoter activity
to 40% of basal values (Fig. 3B).
4. Discussion
The data presented here provide the ¢rst analysis of the 5P-
regulatory region of the SSTR3 gene; two features become
apparaent from this analysis that distinguish rSSTR3 from
the other SSTRs: ¢rst, the 5P-UTR is by far the longest
among those SSTR genes characterized so far [6,14,15]. Sec-
ondly, SSTR3 contains two introns upstream of its transla-
tional start codon which were identi¢ed by comparing the
cDNA sequence with that of the genomic clone. A similar
observation was made only with the mouse SSTR2 cDNA,
which contains two small exons at its 5P-end which are sepa-
rated by large introns of about 25 kb [5]. Whereas these give
rise to di¡erentially spliced isoforms, no signs of alternative
splicing were detected during sequence analysis of the SSTR3
cDNA [4].
Our functional analysis of the SSTR3 promoter region
clearly shows that the sequence upstream of the second tran-
scriptional start site at position 3856 confers cell type speci¢c
expression of the receptor. Thus, while the promoter is func-
tional in GH3 cells, which express endogenous SSTR3 at mod-
erate levels, no promoter activity was observed in HEK cells
which are devoid of endogenous SSTRs. In addition, a factor
from GH3 (and not HEK) nuclear extracts speci¢cally binds
to the promoter region upstream of the second transcriptional
start site which is su⁄cient to initiate transcription in GH3
cells (data not shown). So far the identity of this tissue-speci¢c
transcription factor for SSTR3 has not been resolved.
Although consensus sequences for the transcription factors
Sp1, GCF and Y1 have been identi¢ed, these factors are
rather ubiquitously expressed and are therefore not likely to
be involved in the tissue-speci¢c regulation of SSTR3.
We detected one consensus sequence for the transcription
factor Pit-1 in the rSSTR3 promoter (31394 to 31387). Pit-1
is responsible for the GH3-cell speci¢c expression of the
rSSTR1 gene (Baumeister, Wegner, Richter and Meyerhof,
manuscript submitted), but it is obviously not required for
expression of rSSTR3 in the same cells as it can be deleted
without any e¡ect on promoter activity. This further illus-
trates the di¡erential regulation of SSTR gene expression in
one particular cell type.
The 5P region of the investigated genomic clones appears to
suppress SSTR3 promoter activity. This inhibitory e¡ect be-
came evident upon linkage of this region to the pGL3 basic
vector and transfection into GH3 cells. One possible explan-
ation is the occurrence of a sequence (31607 to 31587) which
bears similarity to a consensus sequence for a neuronal re-
strictive silencer element [16]. Binding of a nuclear protein
(which is not expressed in neurons) to this sequence restricts
gene expression in non-neuronal tissues. This mechanism
might be responsible for the rather low expression of rSSTR3
in GH3 cells.
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